Moxifloxacin Stulln Sine (Moxifloxacin)

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibition of these enzymes stops bacterial cell division, leading to bacterial death and clearance of the infection from the ocular surface.

The dosing regimen for Moxifloxacin Stulln Sine is determined by the prescribing clinician based on the specific infection, severity, and patient characteristics. Healthcare professionals set the frequency and duration of eye‑drop administration.

Safety data for ocular moxifloxacin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers broad‑spectrum coverage against both Gram‑positive and Gram‑negative bacteria and has a higher potency than many older fluoroquinolones. Compared with agents such as ciprofloxacin, it often requires fewer daily applications and may achieve faster bacterial eradication.

Store the ophthalmic solution at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from light and moisture, and discard any product that appears discolored or cloudy.

The medication is applied as eye drops directly onto the affected eye(s). The prescriber will instruct the patient on the number of drops per dose, the frequency of administration, and any necessary precautions such as eyelid closure after instillation.

Serious risks include severe allergic reactions, corneal ulceration or perforation, and rare systemic effects such as tendon rupture or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience intense pain, vision changes, swelling, or signs of an allergic response.

Individuals with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any component of the formulation should avoid this product. It is also contraindicated in patients with a history of tendon disorders related to fluoroquinolone use.